| Southern Region Community Health Center | |
|
162 Abman Drive Inarajan GU 96915-2816 | |
| (671) 828-7501 | |
| (671) 828-7504 |
| Full Name | Southern Region Community Health Center |
|---|---|
| Speciality | Clinic/center - Federally Qualified Health Center (fqhc) |
| Location | 162 Abman Drive, Inarajan, Guam |
| Authorized Official Name and Position | Linda Unpingco Denorcey (EXECUTIVE DIRECTOR) |
| Authorized Official Contact | 6716354422 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Southern Region Community Health Center 162 Abman Drive Inarajan GU 96915-2816 Ph: (671) 828-7501 | Southern Region Community Health Center 162 Abman Drive Inarajan GU 96915-2816 Ph: (671) 828-7501 |
| NPI Number | 1629041546 |
|---|---|
| Provider Enumeration Date | 02/10/2006 |
| Last Update Date | 04/12/2013 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629041546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QF0400X | Clinic/center - Federally Qualified Health Center (fqhc) | (Guam) | Primary |
News Archive
Charité - Universitätsmedizin Berlin has developed a unique measuring method which permits medical personnel, within minutes, to say whether the lifestyle of a person is healthy or unhealthy. This process is now being tested with the support of the Competence Networks for optical Technologies, in a pilot study with 50 students, supported by OpticNet Deutschland e.V. and funded by the Federal Ministry for Education and Research.
It's time to pucker up for a cause! Beginning today, David's Bridal will donate $1 (up to $100,000) to Bright Pink for every kiss sent on Instagram and Twitter using the hashtag #WithAKiss!
KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has secured an initial funding round of $2.5 million from four investors – three biotechnology venture capital groups and one angel investor. The round will finance a clinical trial and laboratory testing of a new, minimally invasive blood test designed to identify risks to pregnancy ranging from pre-term birth to genetic conditions.
A team of global scientists, led by researchers at Intermountain Medical Center in Salt Lake City, has developed a safer and more accurate way to administer warfarin, one of the most commonly prescribed but also potentially dangerous medications in the United States.
Tourette syndrome, a neurodevelopmental disorder, causes motor and phonic "tics" or uncontrollable repeated behaviors and vocalizations. People affected by Tourette syndrome can often suppress these tics for some time before the urges become overwhelming, and researchers have long wondered at the neural underpinnings of the suppression effort.
› Verified 8 days ago